Pharmaceutical News
More stories
-
T-cell Lymphoma Market Growth Insight Share Size Major
Hodgkin Lymphoma – An Overview of the Disease and Clinical Pipeline Introduction Hodgkin lymphoma (HL), also known as B-cell Hodgkin lymphoma, is a cancer of the lymphatic system. It is a rare disease, accounting for only about 0.5% of all new cancer cases each year in the United States. However, advances in research have led […] More
-
Sarepta Therapeutics Expands US FDA Approval for ELEVIDYS in Duchenne!
Sarepta Therapeutics Announces FDA Approval of ELEVIDYS Sarepta Therapeutics, the leader in precision genetic medicine for rare diseases, has announced the expansion of the ELEVIDYS label to include individuals with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are at least 4 years of age. The FDA granted traditional approval […] More
-
Pfizer’s PF-08046044: Will it Be Approved for Diffuse Large B-Cell Lymphoma?
PF-08046044: A Promising Drug Candidate for the Treatment of Lymphomas PF-08046044, also known as SGN-35C, is a next-generation CD30-directed antibody conjugated with topoisomerase I inhibitor payload. It is currently in Phase I of clinical development by Pfizer for the treatment of lymphomas, including Hodgkin lymphoma (cHL), peripheral T cell lymphoma (PTCL), diffuse large B cell […] More
-
J&J’s Tremfya Fails GCA Study, Roche and AbbVie Succeed
Johnson & Johnson’s Tremfya Fails in Phase 2 Johnson & Johnson’s Tremfya, a popular drug for treating psoriasis, has hit a roadblock with its recent failure in a Phase 2 clinical trial. The Importance of Tremfya for Psoriasis Patients Tremfya has been a breakthrough for people struggling to manage psoriasis symptoms. The drug, which is […] More
-
Regeneron Pharmaceuticals Stock: Friday’s Movements Unraveled by TradingView
Regeneron’s Odronextamab Receives Positive CHMP Opinion for Relapsed/Refractory Lymphoma Introduction On Friday, Regeneron Pharmaceuticals Inc announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending conditional approval of odronextamab for relapsed/refractory follicular lymphoma (FL) or diffuse large B-cell lymphoma (DLBCL), after two or more lines of […] More
-
Genentech Releases Exciting Press Releases on July 3, 2024
Phase II/III SKYSCRAPER-06 study evaluating tiragolumab plus Tecentriq and chemotherapy did not meet primary endpoints Overview Genentech, a member of the Roche Group, announced that the Phase II/III SKYSCRAPER-06 study evaluating tiragolumab plus Tecentriq and chemotherapy did not meet the primary endpoints of progression-free survival and overall survival for people with previously untreated, locally advanced […] More
-
HUTCHMED Stock Gains Momentum on Friday as Per Benzinga
HUTCHMED’s Tazemetostat NDA Accepted with Priority Review in China for Lymphoma Treatment Overview HUTCHMED HCM stock is trading higher on Friday following the company’s announcement that its New Drug Application (NDA) for Tazemetostat for the treatment of relapsed or refractory follicular lymphoma was accepted in China with Priority Review status. The China National Medical Products […] More
-
“Powerball Winning Numbers Revealed: $20 Million Jackpot Up for Grabs!”
Powerball Lottery: How to Play and Increase Your Chances of Winning Are you feeling lucky? The Powerball lottery jackpot has reset to $20 million for Saturday’s drawing after a lucky winner in Ohio claimed the previous jackpot. If you’re interested in trying your luck, here’s what you need to know about playing the Powerball lottery. […] More
-
Ethylene Vinyl Infusion Bag Market Share & Market Analysis – openPR.com
Mobile Computerized Tomography (CT) Market Overview Mobile Computerized Tomography (CT) is a diagnostic imaging tool used to visualize internal organs, bones, soft tissue, and blood vessels in high detail. This technology helps healthcare providers quickly and accurately assess a patient’s condition, leading to more timely and effective treatment. The global Mobile CT Market is expected […] More
-
NICE U-Turn: Hemgenix Reimbursement Recommendation for Hemophilia News Today
UK Recommends Hemgenix Gene Therapy for Hemophilia B Coverage Under NHS's Innovative Medicines Fund The UK’s National Institute for Health and Care Excellence (NICE) has reversed its previous recommendation and now suggests that the National Health Service (NHS) should offer reimbursement for Hemgenix (etranacogene dezaparvovec) to eligible adults with hemophilia B. The treatment will come […] More
-
Popular
“Powerball Winning Numbers Revealed: $20 Million Jackpot Up for Grabs!”
Powerball Lottery: How to Play and Increase Your Chances of Winning Are you feeling lucky? The Powerball lottery jackpot has reset to $20 million for Saturday’s drawing after a lucky winner in Ohio claimed the previous jackpot. If you’re interested in trying your luck, here’s what you need to know about playing the Powerball lottery. […] More